Easy-to-use tool can identify high- and low-risk metastatic prostate cancer patients earlier

A new study published in Nature Communications provides a framework for researching whether earlier, model-guided treatment intensification can meaningfully improve survival for patients with aggressive disease.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup